LTS LOHMANN Therapie-Systeme AG Expands CDMO Portfolio with U.S.-Based Ophthalmic Drug Delivery Services

LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, announced the expans...

April 01, 2026 | Wednesday | News
Kytopen Corp., T-CURX GmbH, and Fraunhofer Institute for Cell Therapy and Immunology (IZI) Launch Cell Therapy Center of Excellence in Germany

Kytopen partners with T-CURX and the Fraunhofer Institute for Cell Therapy and Immunology (IZI) in Würzburg and Leipzig, Germany to establish a jo...

May 01, 2026 | Friday | News
Thermo Fisher Scientific Opens Flagship Bioprocess Design Center in Massachusetts to Accelerate Biologics Development

  Expansion of Plainville, Mass., facility offers bioprocessing expertise, advanced technologies and customized support Thermo Fisher Scientific Inc...

April 29, 2026 | Wednesday | News
Thermo Fisher Scientific to Divest Microbiology Unit to Astorg in $1.075 Billion Deal

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it has signed a definitive agreement to sell its microbiol...

April 29, 2026 | Wednesday | News
PCI Pharma Services Commits Over $1 Billion to Expand Sterile Fill-Finish and Drug-Device Capabilities Across US and Europe

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on i...

April 29, 2026 | Wednesday | News
AbbVie Confident in Rapid Path Forward After U.S. Food and Drug Administration Flags Manufacturing Issues in TrenibotE Review

U.S. Food and Drug Administration (FDA) issues Complete Response Letter (CRL) for trenibotulinumtoxinE (TrenibotE) related to manufacturing processes; ...

April 27, 2026 | Monday | News
Marc N. Casper Signals Strong Start To 2026 As Thermo Fisher Scientific Advances Growth Strategy And Innovation Pipeline

  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended Ma...

April 24, 2026 | Friday | Company results
OrganaBio and RxMP Therapeutics Forge cGMP Manufacturing Partnership for First-in-Class Hemostatic Therapy

OrganaBio, LLC ("OrganaBio"), a vertically integrated blood and cell products and services company delivering end-to-end solutions for cell and gene ther...

April 24, 2026 | Friday | News
AbbVie Commits $1.4B to Build North Carolina Manufacturing Campus in Largest-Ever Site Investment

Marks AbbVie's largest-ever capital investment in a single campus since its inception Investment demonstrates continued progress a...

April 24, 2026 | Friday | News
WuXi Biologics Secures South Korea MFDS GMP Certification for Three Wuxi Facilities

 WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manu...

April 24, 2026 | Friday | News
Evonik Industries Commits €80M to Expand Biotechnology Capabilities at Slovenská Ľupča Fermas Site

Marks the second major investment at the Slovenská Ľupča site in recent years Follows the group’s strategy to strengthen leading ...

April 23, 2026 | Thursday | News
Andelyn Biosciences and ENCell Co., Ltd. Forge Strategic Alliance to Accelerate Global Gene Therapy Manufacturing

Andelyn Biosciences, (“Andelyn”) a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (&ldqu...

April 23, 2026 | Thursday | News
Making Nucleic Acid Therapeutics Manufacturing More Sustainable at Scale

The demand for nucleic acid therapeutics (NATs) is rapidly altering the therapeutic landscape across a wide range of diseases. Recent industry data highlig...

April 20, 2026 | Monday | Expert Opinion
Repligen Opens New Training & Innovation Center in the Netherlands to Strengthen Global Bioprocessing Support

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its new ...

April 20, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close